Even though it is well tolerated, it can cause mild gastrointestinal side effects where the blood supply to the colon is reduced, leading to conditions like Colon ischemia
In other words, EllieMD appears to be borrowing clinical evidence from injectable formulations and applying it to a fundamentally different delivery method
Compounding pharmacies adjust dosing to compensate, but the clinical literature on oral compounded GLP-1 efficacy is thinner than for the injectable forms
Both reduce appetite and are used alongside diet and activity changes, but current NICE guidance concludes that tirzepatide is more effective overall than semaglutide for managing overweight and obesity
While the delivery method changes, the goal remains the same: to support appetite control and sustainable weight management through medically guided treatment
Schedule your physician-guided consultation and receive personalized care designed around your health goals